πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 1,157 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 9790261

Codon optimized IL-15 and IL-15R-alpha genes for expression in mammalian cells

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Oct 17 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 12 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9782399

Pharmaceutical compositions which inhibit FKBP52-mediated regulation of androgen receptor

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Oct 10 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 05 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9783595

Neutralizing GP41 antibodies and their use

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Oct 10 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 05 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9783787

Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3β€²-UTR of den

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Oct 10 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 05 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9783586

Inhibitors of the linear ubiquitin chain assembly complex (LUBAC) and related methods

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Oct 10 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 05 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9782465

Serologic correlates of protection against Bacillus anthracis infection

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Oct 10 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 05 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9775895

HIV therapeutics and methods of making and using same

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Oct 03 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 28 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9771428

CD47 targeted therapies for the treatment of infectious disease

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Sep 26 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 21 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9765063

Amido compounds as RORΞ³t modulators and uses thereof

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Sep 19 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 14 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9764022

Methods and compositions for inhibiting polyomavirus-associated pathology

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Sep 19 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 14 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9765342

Chimeric antigen receptors targeting B-cell maturation antigen

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Sep 19 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 14 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9765142

TEM8 antibodies and their use in treatment and detection of tumors

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Sep 19 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 14 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9765123

Pseudomonas exotoxin a with less immunogenic T cell and/or B cell epitopes

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Sep 19 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 14 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9765031

Cannabinoid receptor mediating compounds

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Sep 19 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 14 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9751931

Hepatitis C virus neutralizing antibodies and methods

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Sep 05 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 31 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9750793

Multifunctional oral vaccine based on chromosome recombineering

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Sep 05 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 31 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9738703

Neutralizing antibodies to HIV-1 and their use

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Aug 22 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 17 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9738726

HER2-specific monoclonal antibodies and conjugates thereof

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Aug 22 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 17 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9732359

Replication-competent adenoviral vectors

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Aug 15 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 10 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9730993

Engineered anthrax lethal toxin for targeted delivery

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Aug 15 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 10 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9730941

Methods and compositions for the inhibition of Pin1

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Aug 15 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 10 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9725492

Codon optimized IL-15 and IL-15R-alpha genes for expression in mammalian cells

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Aug 08 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 03 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9717752

Uses of antagonists of hyaluronan signaling

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Aug 01 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 27 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9719080

Synthetic methylmalonyl-CoA mutase transgene for the treatment of MUT class methylmalonic

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Aug 01 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 27 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted